Public limited company · Merelbeke-Melle · incorporated on 11/01/2010
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 116,4 k € | -3.4% | 120,6 k € | +14.1% | 105,6 k € | -1.1% | 106,8 k € | -2.5% | 109,6 k € | +3.6% | 105,8 k € | -16.3% | 126,5 k € | +10.9% | 114,1 k € | +17.4% | 97,2 k € | -4.8% | 102,1 k € | -1.3% | 103,4 k € | +1.0% | 102,4 k € | -9.0% | 112,4 k € | +8.7% | 103,4 k € | |
| EBITDA | 112,2 k € | -3.6% | 116,3 k € | +14.6% | 101,6 k € | -1.5% | 103,1 k € | -2.7% | 106,0 k € | +3.7% | 102,2 k € | -17.0% | 123,1 k € | +11.1% | 110,8 k € | +18.0% | 93,9 k € | -5.0% | 98,9 k € | -1.4% | 100,2 k € | +1.1% | 99,2 k € | -7.6% | 107,4 k € | +6.9% | 100,4 k € | |
| Operating profit | 52,0 k € | -9.4% | 57,4 k € | +33.9% | 42,9 k € | +3.2% | 41,5 k € | -8.2% | 45,2 k € | +64.4% | 27,5 k € | -43.1% | 48,4 k € | +28.4% | 37,7 k € | +63.1% | 23,1 k € | -17.7% | 28,1 k € | -3.1% | 29,0 k € | +1.8% | 28,4 k € | -22.9% | 36,9 k € | +19.5% | 30,9 k € | |
| Profit/loss | 30,1 k € | +1.4% | 29,7 k € | +56.2% | 19,0 k € | -15.4% | 22,5 k € | -16.4% | 26,9 k € | +116.5% | 12,4 k € | -65.1% | 35,6 k € | +37.5% | 25,9 k € | +133.3% | 11,1 k € | -23.8% | 14,6 k € | +49.0% | 9,8 k € | +50.8% | 6,5 k € | -58.8% | 15,7 k € | +159.9% | 6,1 k € | |
| Equity | 220,3 k € | -3.0% | 227,2 k € | +15.0% | 197,5 k € | +10.7% | 178,5 k € | +14.4% | 156,0 k € | +20.8% | 129,1 k € | +10.6% | 116,7 k € | +43.9% | 81,1 k € | +46.9% | 55,2 k € | +25.2% | 44,1 k € | +49.3% | 29,5 k € | +49.5% | 19,8 k € | +48.8% | 13,3 k € | +636.5% | -2,5 k € | |
| Total assets | 485,9 k € | -9.9% | 539,2 k € | -4.6% | 565,4 k € | -21.8% | 723,3 k € | -4.3% | 755,5 k € | -4.6% | 791,7 k € | -7.3% | 853,6 k € | -3.4% | 883,5 k € | -4.5% | 925,1 k € | -5.9% | 983,4 k € | -5.1% | 1,0 M € | -5.2% | 1,1 M € | -5.1% | 1,2 M € | -4.5% | 1,2 M € | |
| Cash | 24,8 k € | -52.6% | 52,3 k € | +105.6% | 25,5 k € | -81.1% | 135,0 k € | +26.7% | 106,5 k € | +10.2% | 96,7 k € | +12.2% | 86,1 k € | +13.8% | 75,7 k € | +29.2% | 58,6 k € | +12.5% | 52,1 k € | +35.1% | 38,5 k € | +47.7% | 26,1 k € | +33.7% | 19,5 k € | +62.7% | 12,0 k € | |
| Debts | 265,6 k € | -14.9% | 312,0 k € | -13.7% | 361,6 k € | -32.9% | 539,1 k € | -9.3% | 594,1 k € | -9.5% | 656,5 k € | -10.2% | 730,8 k € | -8.2% | 796,2 k € | -7.8% | 863,7 k € | -8.0% | 939,3 k € | -6.5% | 1,0 M € | -6.2% | 1,1 M € | -5.8% | 1,1 M € | -5.7% | 1,2 M € | |
Public limited company profitable and well capitalised. Cash position declining (-52.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MEDINVAS is a Public limited company incorporated in 2010. Its registered office is in Merelbeke-Melle.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.